A review of the differences and similarities between generic drugs and their originator counterparts, including economic benefits associated with usage of generic medicines, using Ireland as a case study

Peer Review reports

Original Submission
5 Jun 2012	Submitted	Original manuscript
30 Aug 2012	Author responded	Author comments - Suzanne Dunne
6 May 2012	Reviewed	Reviewer Report - Zaheer Babar
31 May 2012	Reviewed	Reviewer Report - Atholl Johnston
6 Jun 2012	Reviewed	Reviewer Report - Brian Godman
Resubmission - Version 2
30 Aug 2012	Submitted	Manuscript version 2
20 Nov 2012	Author responded	Author comments - Suzanne Dunne
10 Oct 2012	Reviewed	Reviewer Report - Zaheer Babar
4 Oct 2012	Reviewed	Reviewer Report - Atholl Johnston
4 Oct 2012	Reviewed	Reviewer Report - Brian Godman
Resubmission - Version 3
20 Nov 2012	Submitted	Manuscript version 3
Resubmission - Version 4
	Submitted	Manuscript version 4
22 Dec 2012	Author responded	Author comments - Suzanne Dunne
Resubmission - Version 5
22 Dec 2012	Submitted	Manuscript version 5
Publishing
24 Dec 2012	Editorially accepted
5 Jan 2013	Article published	10.1186/2050-6511-14-1

Back to article page